2021 ICOS多学科专家共识声明:治疗性放疗的心血管表现

2021-09-21 国际心脏肿瘤学会 JACC: CARDIOONCOLOGY

2021年9月,国际心脏肿瘤学会(ICOS)发布了治疗性放疗的心血管表现的多学科专家共识。放射治疗是癌症治疗的基石,超过50%的癌症患者接受放射治疗。

中文标题:

2021 ICOS多学科专家共识声明:治疗性放疗的心血管表现

英文标题:

Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology Society

发布机构:

国际心脏肿瘤学会

发布日期:

2021-09-21

简要介绍:

2021年9月,国际心脏肿瘤学会(ICOS)发布了治疗性放疗的心血管表现的多学科专家共识。放射治疗是癌症治疗的基石,超过50%的癌症患者接受放射治疗。放射治疗可导致血管系统动脉粥样硬化以及瓣膜、心肌和心包功能障碍。本文针对接受放射治疗患者的心血管的管理和随访提供指导建议。

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 ICOS多学科专家共识声明:治疗性放疗的心血管表现.pdf)] GetToolGuiderByIdResponse(projectId=1, id=af6641c002201a55, title=2021 ICOS多学科专家共识声明:治疗性放疗的心血管表现, enTitle=Cardiovascular Manifestations From Therapeutic Radiation: A Multidisciplinary Expert Consensus Statement From the International Cardio-Oncology Society, guiderFrom=JACC: CARDIOONCOLOGY, authorId=0, author=, summary=2021年9月,国际心脏肿瘤学会(ICOS)发布了治疗性放疗的心血管表现的多学科专家共识。放射治疗是癌症治疗的基石,超过50%的癌症患者接受放射治疗。, cover=https://img.medsci.cn/2021109/1633771462593_5579292.jpg, journalId=0, articlesId=null, associationId=1999, associationName=国际心脏肿瘤学会, associationIntro=国际心脏肿瘤学会(ICOS,International Cardio-Oncology Society), copyright=0, guiderPublishedTime=Tue Sep 21 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">2021年9月,国际心脏肿瘤学会(ICOS)发布了治疗性放疗的心血管表现的多学科专家共识。放射治疗是癌症治疗的基石,超过50%的癌症患者接受放射治疗。放射治疗可导致血管系统动脉粥样硬化以及瓣膜、心肌和心包功能障碍。本文针对接受放射治疗患者的心血管的管理和随访提供指导建议。</span></p>, tagList=[TagDto(tagId=115751, tagName=治疗性放疗)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=804, guiderKeyword=放疗, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=10, opened=0, paymentType=, paymentAmount=2, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=68940, appHits=77, showAppHits=0, pcHits=2627, showPcHits=68863, likes=0, shares=7, comments=6, approvalStatus=1, publishedTime=Sat Oct 09 17:31:29 CST 2021, publishedTimeString=2021-09-21, pcVisible=1, appVisible=1, editorId=1614372, editor=MedSciZeng, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Sat Oct 09 17:25:08 CST 2021, updatedBy=1614372, updatedName=MedSciZeng, updatedTime=Fri Jan 05 18:53:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ICOS多学科专家共识声明:治疗性放疗的心血管表现.pdf)])
2021 ICOS多学科专家共识声明:治疗性放疗的心血管表现.pdf
下载请点击:
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1188815, encodeId=0e381188815a6, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8de6465631, createdName=ms7000000671946062, createdTime=Fri Jan 28 13:52:27 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080072, encodeId=570710800e2b9, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7903132472, createdName=anyangcuizhiying, createdTime=Tue Dec 14 21:03:47 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074218, encodeId=c09710e4218c6, content=不错 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:12:33 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059206, encodeId=acf1105920699, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Sun Oct 10 16:39:30 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059113, encodeId=18c3105911345, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12a25573232, createdName=ms4000000314404532, createdTime=Sun Oct 10 08:07:25 CST 2021, time=2021-10-10, status=1, ipAttribution=)]
    2022-01-28 ms7000000671946062

    学习好资料

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1188815, encodeId=0e381188815a6, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8de6465631, createdName=ms7000000671946062, createdTime=Fri Jan 28 13:52:27 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080072, encodeId=570710800e2b9, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7903132472, createdName=anyangcuizhiying, createdTime=Tue Dec 14 21:03:47 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074218, encodeId=c09710e4218c6, content=不错 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:12:33 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059206, encodeId=acf1105920699, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Sun Oct 10 16:39:30 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059113, encodeId=18c3105911345, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12a25573232, createdName=ms4000000314404532, createdTime=Sun Oct 10 08:07:25 CST 2021, time=2021-10-10, status=1, ipAttribution=)]
    2021-12-14 anyangcuizhiying

    非常棒

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1188815, encodeId=0e381188815a6, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8de6465631, createdName=ms7000000671946062, createdTime=Fri Jan 28 13:52:27 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080072, encodeId=570710800e2b9, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7903132472, createdName=anyangcuizhiying, createdTime=Tue Dec 14 21:03:47 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074218, encodeId=c09710e4218c6, content=不错 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:12:33 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059206, encodeId=acf1105920699, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Sun Oct 10 16:39:30 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059113, encodeId=18c3105911345, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12a25573232, createdName=ms4000000314404532, createdTime=Sun Oct 10 08:07:25 CST 2021, time=2021-10-10, status=1, ipAttribution=)]
    2021-11-26 H8888888

    不错 学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1188815, encodeId=0e381188815a6, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8de6465631, createdName=ms7000000671946062, createdTime=Fri Jan 28 13:52:27 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080072, encodeId=570710800e2b9, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7903132472, createdName=anyangcuizhiying, createdTime=Tue Dec 14 21:03:47 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074218, encodeId=c09710e4218c6, content=不错 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:12:33 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059206, encodeId=acf1105920699, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Sun Oct 10 16:39:30 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059113, encodeId=18c3105911345, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12a25573232, createdName=ms4000000314404532, createdTime=Sun Oct 10 08:07:25 CST 2021, time=2021-10-10, status=1, ipAttribution=)]
    2021-10-10 ms6000001387765207

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1188815, encodeId=0e381188815a6, content=学习好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8de6465631, createdName=ms7000000671946062, createdTime=Fri Jan 28 13:52:27 CST 2022, time=2022-01-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1080072, encodeId=570710800e2b9, content=非常棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b7903132472, createdName=anyangcuizhiying, createdTime=Tue Dec 14 21:03:47 CST 2021, time=2021-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074218, encodeId=c09710e4218c6, content=不错 学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=989a5607928, createdName=H8888888, createdTime=Fri Nov 26 14:12:33 CST 2021, time=2021-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059206, encodeId=acf1105920699, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=145, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Sun Oct 10 16:39:30 CST 2021, time=2021-10-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1059113, encodeId=18c3105911345, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=148, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=12a25573232, createdName=ms4000000314404532, createdTime=Sun Oct 10 08:07:25 CST 2021, time=2021-10-10, status=1, ipAttribution=)]
    2021-10-10 ms4000000314404532

    学习

    0

拓展阅读

2016 MASCC/ESMO共识建议:放疗相关恶心呕吐的预防  

癌症支持疗法多国学会(MASCC,Multinational Association of Supportive Care in Cancer) · 2016-09-13

头颈部肿瘤放疗者营养与支持治疗专家共识

中国抗癌协会肿瘤营养与支持治疗专业委员会 · 2018-01-03

胶质瘤放疗中国专家共识(2017)

中华医学会放射肿瘤学会 · 2018-02-07

2018 ESTRO指南:局部进展期非小细胞肺癌治疗中靶区定义

欧洲放射肿瘤学学会(ESTRO,European Society of Radiotherapy & Oncology) · 2018-03-28

原发性肝癌放疗的指南推荐解读

暂未更新 · 2018-05-10

2020 ESTRO/ASTRO共识声明:COVID-19流行期间肺癌的放疗建议

欧洲放射肿瘤学学会(ESTRO,European Society of Radiotherapy & Oncology) · 2020-04-06